Kaempferol upregulates the expression of Bcl-xL and downregulates that of p53 and Bax by inhibiting extracellular regulated protein kinases (ERK), NF-κB, and MyD88 expression in human ovarian cancer cells [59]. Here, NFKB1 is linked to ovarian carcinoma.